Press Release | January 22, 2023
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
Read More
Press Release | January 18, 2023
Freenome Partners with Geisinger for the Sanderson Study
Read More
Education | January 12, 2023
Agent Capital’s Associate, Jonathan Ark’s PhD Work Published in Cell
Read More
Press Release | January 11, 2023
Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)
Read More
